Concepedia

Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation

Syed Mohammad Ali Kazmi, Maliha Nusrat, Hilal Gunaydin, Amanda Megan Cornelison, Nina Shah, Partow Kebriaei, Yago Nieto, Simrit Parmar, Uday Popat, Betül Oran,

Clinical Lymphoma Myeloma & Leukemia · 2015 · 44 citations · 17 references

DOIFull text

Open access

Concepts

References

17

International uniform response criteria for multiple myeloma

Brian G.M. Durie, J-L Harousseau, Jesús F. San Miguel et al. · Leukemia · 2006 · 2.6K citations

, , +12

Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

Michel Attal, Valérie Lauwers‐Cancès, Gérald Marit et al. · New England Journal of Medicine · 2012 · 1.2K citations · Full text

, , +13

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister et al. · New England Journal of Medicine · 2012 · 1.1K citations · Full text

, , +15

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome

Hervé Avet‐Loiseau, Michel Attal, Philippe Moreau et al. · Blood · 2007 · 905 citations · Full text

, , +15

Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p)

Hervé Avet‐Loiseau, Xavier Leleu, Murielle Roussel et al. · Journal of Clinical Oncology · 2010 · 424 citations · Full text

, , +10